CDKN2B and lung carcinoma: A recent meta-analysis of lung cancer GWASs by TRICL found rs1333040, which is approximately 74kb upstream from CDKN2B, to be associated with lung cancer (OR = 1.06; P = 9.4×10–5), with a stronger association for SCC (OR = 1.14; P = 2.9×10–7) (11).